FOXP3 + regulatory and TIA-1 + cytotoxic T lymphocytes in HIV-associated Hodgkin lymphoma

Pathology International

Volumn 62, Issue 2, 2012, Pages 77-83

  Kiyasu, Junichi ^a,b   Aoki, Ryosuke ^a   Tanaka, Paula Yurie ^d   Pracchia, Luis Fernando ^e   Calore, Edenilson Eduardo ^d   Perez, Nilda Maria ^d   Kimura, Yoshizo ^a   Niino, Daisuke ^a   Sugita, Yasuo ^a   Takayanagi, Ryoichi ^b   Abe, Yasunobu ^b   Matsuoka, Masao ^c   Ohshima, Koichi ^a  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

^c KYOTO UNIVERSITY   (Japan)

^d INSTITUTO DE INFECTOLOGIA EMÍLIO RIBAS   (Brazil)

^e Secretaria Municipal da Saúde da Prefeitura Municipal de São Paulo   (Brazil)

Author keywords

EBV; HIV associated lymphoma; HIV AIDS; Hodgkin lymphoma; Regulatory T cell

Indexed keywords

EPSTEIN BARR VIRUS ANTIGEN 2; TRANSCRIPTION FACTOR FOXP3;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; DISEASE ASSOCIATION; EPSTEIN BARR VIRUS; FEMALE; HISTOPATHOLOGY; HODGKIN DISEASE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; PATHOGENESIS; PRIORITY JOURNAL; T LYMPHOCYTE;

ADULT; FORKHEAD TRANSCRIPTION FACTORS; HIV; HIV INFECTIONS; HODGKIN DISEASE; HUMANS; MALE; POLY(A)-BINDING PROTEINS; REED-STERNBERG CELLS; T-LYMPHOCYTES, CYTOTOXIC;

EID: 84855969325     PISSN: 13205463     EISSN: 14401827     Source Type: Journal    
DOI: 10.1111/j.1440-1827.2011.02754.x     Document Type: Article

References (40)

1. Knowles DM. Etiology and pathogenesis of AIDS-related non-Hodgkin's lymphoma. Hematol Oncol Clin North Am 2003; 17: 785-820.
2. Grogg KL, Miller RF, Dogan A. HIV infection and lymphoma. J Clin Pathol 2007; 60: 1365-72.
3. Knowles DM, Chamulak GA, Subar M etal. Lymphoid neoplasia associated with the acquired immunodeficiency syndrome (AIDS). The New York University Medical Center experience with 105 patients (1981-1986). Ann Intern Med 1988; 108: 744-53.
4. Levine AM, Meyer PR, Begandy MK etal. Development of B-cell lymphoma in homosexual men. Clinical and immunologic findings. Ann Intern Med 1984; 100: 7-13.
5. Krause J. AIDS-related non-Hodgkin's lymphomas. Microsc Res Tech 2005; 68: 168-75.
6. Raphael M, Said J, Borisch B, Caesarman E, Harris NL. Lymphomas associated with HIV infection. In: Swerdlow SH, Clampo E, Harris NL etal., eds. World Health Organization Classification of Tumors, WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. Lyon: IARC press, 2008; 340-2.
7. Camilleri-Broet S, Davi F, Feuillard J etal. AIDS-related primary brain lymphomas: Histopathologic and immunohistochemical study of 51 cases. The French Study Group for HIV-Associated Tumors. Hum Pathol 1997; 28: 367-74.
8. Hamilton-Dutoit SJ, Raphael M, Audouin J etal. In situ demonstration of Epstein-Barr virus small RNAs (EBER 1) in acquired immunodeficiency syndrome-related lymphomas: Correlation with tumor morphology and primary site. Blood 1993; 82: 619-24.
9. Hessol NA, Katz MH, Liu JY, Buchbinder SP, Rubino CJ, Holmberg SD. Increased incidence of Hodgkin disease in homosexual men with HIV infection. Ann Intern Med 1992; 117: 309-11.
10. Glaser SL, Clarke CA, Gulley ML etal. Population-based patterns of human immunodeficiency virus-related Hodgkin lymphoma in the Greater San Francisco Bay Area, 1988-1998. Cancer 2003; 98: 300-9.
11. Raphael M, Said J, Borisch B etal. Lymphomas associated with HIV infection. In: Swerdlow SH, Campo E, Harris NL etal., eds. World Health Organization Classification of Tumours of Haematopoietic and Lymphoid Tissues. Lyon: IARC, 2008; 340-42.
12. Engels EA, Pfeiffer RM, Goedert JJ etal. Trends in cancer risk among people with AIDS in the United States 1980-2002. Aids 2006; 20: 1645-54.
13. Herida M, Mary-Krause M, Kaphan R etal. Incidence of non-AIDS-defining cancers before and during the highly active antiretroviral therapy era in a cohort of human immunodeficiency virus-infected patients. J Clin Oncol 2003; 21: 3447-53.
14. Biggar RJ, Jaffe ES, Goedert JJ, Chaturvedi A, Pfeiffer R, Engels EA. Hodgkin lymphoma and immunodeficiency in persons with HIV/AIDS. Blood 2006; 108: 3786-91.
15. Shresta S, MacIvor DM, Heusel JW, Russell JH, Ley TJ. Natural killer and lymphokine-activated killer cells require granzyme B for the rapid induction of apoptosis in susceptible target cells. Proc Natl Acad Sci U S A 1995; 92: 5679-83.
16. Smyth MJ, Street SE, Trapani JA. Cutting edge: Granzymes A and B are not essential for perforin-mediated tumor rejection. J Immunol 2003; 171: 515-8.
17. Poppema S, van den Berg A. Interaction between host T cells and Reed-Sternberg cells in Hodgkin lymphomas. Semin Cancer Biol 2000; 10: 345-50.
18. Poppema S. Regulatory T cells in Hodgkin lymphoma. Blood 2004; 103: 1565-66.
19. Skinnider BF, Mak TW. The role of cytokines in classical Hodgkin lymphoma. Blood 2002; 99: 4283-97.
20. Ishida T, Ishii T, Inagaki A etal. Specific recruitment of CC chemokine receptor 4-positive regulatory T cells in Hodgkin lymphoma fosters immune privilege. Cancer Res 2006; 66: 5716-22.
21. Marshall NA, Christie LE, Munro LR etal. Immunosuppressive regulatory T cells are abundant in the reactive lymphocytes of Hodgkin lymphoma. Blood 2004; 103: 1755-62.
22. Alvaro T, Lejeune M, Salvado MT etal. Outcome in Hodgkin's lymphoma can be predicted from the presence of accompanying cytotoxic and regulatory T cells. Clin Cancer Res 2005; 11: 1467-73.
23. Curiel TJ, Coukos G, Zou L etal. Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nat Med 2004; 10: 942-9.
24. Ohshima K, Takeo H, Kikuchi M etal. Heterogeneity of Epstein-Barr virus infection in angioimmunoblastic lymphadenopathy type T-cell lymphoma. Histopathology 1994; 25: 569-79.
25. Ostrowski MA, Justement SJ, Catanzaro A etal. Expression of chemokine receptors CXCR4 and CCR5 in HIV-1-infected and uninfected individuals. J Immunol 1998; 161: 3195-201.
26. Thompson LD, Fisher SI, Chu WS, Nelson A, Abbondanzo SL. HIV-associated Hodgkin lymphoma: A clinicopathologic and immunophenotypic study of 45 cases. Am J Clin Pathol 2004; 121: 727-38.
27. Audouin J, Diebold J, Pallesen G. Frequent expression of Epstein-Barr virus latent membrane protein-1 in tumour cells of Hodgkin's disease in HIV-positive patients. J Pathol 1992; 167: 381-4.
28. Uccini S, Monardo F, Stoppacciaro A etal. High frequency of Epstein-Barr virus genome detection in Hodgkin's disease of HIV-positive patients. Int J Cancer 1990; 46: 581-5.
29. Kamel OW, Weiss LM, van de Rijn M, Colby TV, Kingma DW, Jaffe ES. Hodgkin's disease and lymphoproliferations resembling Hodgkin's disease in patients receiving long-term low-dose methotrexate therapy. Am J Surg Pathol 1996; 20: 1279-87.
30. Brown SL, Greene MH, Gershon SK, Edwards ET, Braun MM. Tumor necrosis factor antagonist therapy and lymphoma development: Twenty-six cases reported to the Food and Drug Administration. Arthritis Rheum 2002; 46: 3151-8.
31. Pelstring RJ, Zellmer RB, Sulak LE, Banks PM, Clare N. Hodgkin's disease in association with human immunodeficiency virus infection. Pathologic and immunologic features. Cancer 1991; 67: 1865-73.
32. + cytotoxic T lymphocytes in the inflammatory background of HIV-associated Hodgkin's lymphoma. Ann Hematol 2005; 84: 661-6.
33. +) regulatory T cells can mediate suppressor function in the absence of transforming growth factor beta1 production and responsiveness. J Exp Med 2002; 196: 237-46.
34. Lieberman J, Shankar P, Manjunath N, Andersson J. Dressed to kill? A review of why antiviral CD8 T lymphocytes fail to prevent progressive immunodeficiency in HIV-1 infection. Blood 2001; 98: 1667-77.
35. + T-cell response in HIV infection. AIDS Rev 2004; 6: 79-88.
36. + T lymphocyte granules in lymphoid tissue during acute human immunodeficiency virus type 1 infection. J Infect Dis 2002; 185: 1355-8.
37. Ruco LP, Di Napoli A, Pilozzi E etal. Peripheral T cell lymphoma with cytotoxic phenotype: An emerging disease in HIV-infected patients? AIDS Res Hum Retroviruses 2004; 20: 129-33.
38. Zhang D, Shankar P, Xu Z etal. Most antiviral CD8 T cells during chronic viral infection do not express high levels of perforin and are not directly cytotoxic. Blood 2003; 101: 226-35.
39. + patients. Am J Pathol 1995; 146: 1542-55.
40. Kanavaros P, Vlychou M, Stefanaki K etal. Cytotoxic protein expression in non-Hodgkin's lymphomas and Hodgkin's disease. Anticancer Res 1999; 19: 1209-16.